Christopher M. Hoffmann

Author

National Center for Tumor Diseases ORCID

Also Known As

C Hoffmann, C. Hoffmann, C. M. Hoffmann, Christopher Hoffmann, Christopher M Hoffmann, Christopher M. Hoffmann, Christopher M. Hoffmann

Publications

697

Citations

H-Index

Concepts

All Affiliations

National Center for Tumor Diseases German Cancer Research Center Heidelberg University Deutschen Konsortium für Translationale Krebsforschung University Hospital Heidelberg

About

Christopher M. Hoffmann is an author at National Center for Tumor Diseases specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	138
2	Cell Biology	3	3	122
3	Health Sciences	2	2	94
4	Engineering	1	1	32
5	Pathology	1	1	12

Christopher M. Hoffmann

Publications

677

Citations

H-Index

Page 1

	Year	Citations
Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases Sebastian M. Dieter, Claudia R. Ball, Christopher M. Hoffmann, Cell stem cell	2011	299
Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus Patricia Bach, Tobias Abel, Christopher M. Hoffmann, Cancer Research	2013	126
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33 Ninel Azoitei, Christopher M. Hoffmann, Jana M. Ellegast, The Journal of Experimental Medicine Systems BiologyKras Mutant TumorsHsp90 InhibitorsMedicineReceptor Tyrosine Kinase	2012	78
Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts Claudia R. Ball, Felix Oppel, Karl Roland Ehrenberg, EMBO Molecular Medicine	2017	44
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation Sebastian M. Dieter, Klara M. Giessler, Mark Kriegsmann, International Journal of Cancer	2016	34
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer Klara M. Giessler, Kortine Kleinheinz, Daniel Hüebschmann, The Journal of Experimental Medicine EngineeringCancer BiologyTumor BiologyTumor HeterogeneityCancer Cell Biology	2017	32
The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo Sarah Weber, Sebastian E. Koschade, Christopher M. Hoffmann, BMC Cancer	2019	24
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG) Daniel Martin, Teresa Schreckenbach, Paul K. Ziegler, Radiotherapy and Oncology Prognostic FactorsPrimary ChemoradiotherapySurgical OncologyRadiation TherapyMedicine	2022	16
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells Taronish D. Dubash, Christopher M. Hoffmann, Felix Oppel, Cancer Letters Tumor BiologyCancer PathologyTumor HeterogeneityPhenotypic DifferentiationMedicine	2015	12
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practice W. Brückl, Martin Reck, Frank Griesinger, Therapeutic Advances in Medical Oncology	2021	12

Page 1